Drug compounding for veterinary patients

Journal Title: The AAPS Journal - Year 2005, Vol 7, Issue 2

Abstract

Drugs have been compounded for veterinary practice for many years because it has been necessary in the course of routine practice. However, regulations and compliance policy guidelines (CPGs) should be recognized. A new CPG issued in July 2003 listed the current Food and Drug Administration (FDA) limitations on compounding for veterinary medicine. To summarize the guideline: drugs must not be compounded from bulk substances, and the compounding must not constitute, manufacture of a new animal drug. Drug compounding on a case-by-case basis is allowed under the CPG. However, veterinarians and pharmacists must be aware of potential incompatibilities and practices that may interfere with the drug's stability, purity, and/or potency.

Authors and Affiliations

Mark G. Papich

Keywords

Related Articles

Issues and Challenges of Subvisible and Submicron Particulate Analysis in Protein Solutions

The online version of this article (doi:10.1208/s12248-012-9335-8) contains supplementary material, which is available to authorized users.

Recommended reading in population pharmacokinetic pharmacodynamics

Developing the skills or expertise to create useful population pharmacokinetic-pharmacodynamic models can be a daunting task-the level of mathematical and statistical complexity is such that newcomers to the field are fr...

Inactivation of hepatic enzymes by inhalant nitrite—In vivo and in vitro studies

We examined the effects of acute isobutyl nitrite (ISBN) exposure on the activity of several hepatic enzymes. Two strains of adult male mice (Balb/c and C57BL/6) were exposed to 900 ppm ISBN or ambient air for 45 minutes...

Strategy to Prevent Drug-Related Hypersensitivity in Folate-Targeted Hapten Immunotherapy of Cancer

Cancer vaccine/immunotherapy rarely involves systemic administration of an immunogenic compound to an actively immunized host. We have developed such a strategy that utilizes folate to deliver antigenic haptens [e.g., fl...

Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene

Five immortalized brain capillary endothelial cell lines (TM-BBB1-5) were established from 3 transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene (Tg mouse). These cell lines expressed act...

Download PDF file
  • EP ID EP681848
  • DOI  10.1208/aapsj070229
  • Views 92
  • Downloads 0

How To Cite

Mark G. Papich (2005). Drug compounding for veterinary patients. The AAPS Journal, 7(2), -. https://www.europub.co.uk/articles/-A-681848